These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27966711)

  • 1. Development of a point-of-care diagnostic for influenza detection with antiviral treatment effectiveness indication.
    Murdock RC; Gallegos KM; Hagen JA; Kelley-Loughnane N; Weiss AA; Papautsky I
    Lab Chip; 2017 Jan; 17(2):332-340. PubMed ID: 27966711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.
    Lee BY; McGlone SM; Bailey RR; Wiringa AE; Zimmer SM; Smith KJ; Zimmerman RK
    PLoS One; 2010 Jun; 5(6):e11284. PubMed ID: 20585642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results.
    Sintchenko V; Gilbert GL; Coiera E; Dwyer D
    J Clin Virol; 2002 Jul; 25(1):15-21. PubMed ID: 12126717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and simple detection of Tamiflu-resistant influenza virus: Development of oseltamivir derivative-based lateral flow biosensor for point-of-care (POC) diagnostics.
    Hwang SG; Ha K; Guk K; Lee DK; Eom G; Song S; Kang T; Park H; Jung J; Lim EK
    Sci Rep; 2018 Aug; 8(1):12999. PubMed ID: 30158601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention, diagnosis, and treatment of influenza: current and future options.
    Poehling KA; Edwards KM
    Curr Opin Pediatr; 2001 Feb; 13(1):60-4. PubMed ID: 11176246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
    van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
    J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and management of influenza. An update.
    Sintchenko V; Dwyer DE
    Aust Fam Physician; 1999 Apr; 28(4):313-7. PubMed ID: 10330753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2009 Nov; 51(1325):89-92. PubMed ID: 20220738
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of newer treatment strategies for influenza.
    Smith KJ; Roberts MS
    Am J Med; 2002 Sep; 113(4):300-7. PubMed ID: 12361816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Impact of Rapid Point-of-Care PCR Influenza Testing in an Urgent Care Setting: a Single-Center Study.
    Benirschke RC; McElvania E; Thomson RB; Kaul KL; Das S
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30602445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitness of neuraminidase inhibitor-resistant influenza A viruses.
    Baranovich T; Webster RG; Govorkova EA
    Curr Opin Virol; 2011 Dec; 1(6):574-81. PubMed ID: 22440915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.
    Nshimyumukiza L; Douville X; Fournier D; Duplantie J; Daher RK; Charlebois I; Longtin J; Papenburg J; Guay M; Boissinot M; Bergeron MG; Boudreau D; Gagné C; Rousseau F; Reinharz D
    Influenza Other Respir Viruses; 2016 Mar; 10(2):113-21. PubMed ID: 26574910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiviral drugs for influenza 2012-2013.
    Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic options for the management of influenza.
    Ison MG; Hayden FG
    Curr Opin Pharmacol; 2001 Oct; 1(5):482-90. PubMed ID: 11764774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza.
    Med Lett Drugs Ther; 2015 Feb; 57(1461):17-9. PubMed ID: 25629811
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamiflu report comes under fire.
    Butler D
    Nature; 2014 Apr; 508(7497):439-40. PubMed ID: 24759392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.